Harel Insurance Investments & Financial Services Ltd. in UnitedHealth Group Incorporated


Harel Insurance Investments & Financial Services Ltd. has reduced the value of UnitedHealth Group IncorporatedNYSE: UNHGet Votes) and 46.5% in the first quarter, according to the company in its latest 13F form filed with the Securities and Exchange Commission. The fund owned 230 shares of the health care provider’s stock after selling 200 shares during the period. Harel Insurance Investments & Financial Services Ltd. holdings in UnitedHealth Group were worth $117,000 at the end of the most recent quarter.

A number of hedge funds and other institutional investors have also recently made changes to their positions in the company. Signature Estate & Investment Advisors LLC boosted its stake in UnitedHealth Group by 1.2% in the first quarter. Signature Estate & Investment Advisors LLC now owns 1,606 shares of the health care conglomerate’s stock valued at $820,000 after buying an additional 19 shares during the period. Steph & Co. increased its stake in shares of UnitedHealth Group by 1.6% in the first quarter. Steph & Co. now owns 1,290 shares of the health care conglomerate’s stock valued at $658,000 after purchasing an additional 20 shares in the last quarter. Palisades Hudson Asset Management LP boosted its stake in shares of UnitedHealth Group by 2.0% in the fourth quarter. Palisades Hudson Asset Management LP now owns 1,078 shares of the health care conglomerate’s stock valued at $542,000 after purchasing an additional 21 shares during the period. Charter Oak Capital Management LLC grew its stake in shares of UnitedHealth Group by 2.4% during the fourth quarter. Charter Oak Capital Management LLC now owns 881 shares of the health care provider’s stock worth $442,000 after purchasing an additional 21 shares during the period. Finally, Oxford Financial Group Ltd. lifted its holdings in shares of UnitedHealth Group by 3.0% in the fourth quarter. Oxford Financial Group Ltd. now owns 720 shares of the health care conglomerate’s stock valued at $362,000 after buying an additional 21 shares during the period. Investors and hedge funds own 87.48% of the company’s stock.

UnitedHealth Group Price Performance

NYSE: UNH opened at $521.41 on Monday. UnitedHealth Group Incorporated has a one year low of $383.12 and a one year high of $553.29. The company has market capitalization of $489.17 billion, a P/E ratio of 27.23, a P/E/G ratio of 1.62 and a beta of 0.77. The company’s fifty-day moving average is $497.56 and its two-hundred-day moving average is $495.01. The company has a debt ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.78.

UnitedHealth Group (NYSE: UNHGet Votes) last released its quarterly earnings data on Friday, July 15th. The health care company reported $5.57 EPS for the quarter, topping the consensus estimate of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to estimates of $79.68 billion. UnitedHealth Group had a margin of 5.95% and a return of 25.45%. The company’s revenue for the quarter was up 12.6% on a year-over-year basis. During the same period last year, the company earned $4.70 per share. Equities analysts expect that UnitedHealth Group Incorporated will post 21.84 earnings per share for the year.

UnitedHealth Group Increases Dividend

The company also announced its third quarterly earnings, which were issued on Tuesday, June 28th. Stockholders of record on Monday, June 20th were issued a $1.65 dividend. The company paid $6.60 per share last time and the annual yield was 1.27%. The last day for this session was Thursday, June 16th. The company UnitedHealth Group Limited gave a total of 1.45 $. UnitedHealth Group’s average payout ratio is currently 34.46%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on UNH. Truist Financial boosted their price objective on shares of UnitedHealth Group from $575.00 to $610.00 in a report on Thursday, April 7th. Oppenheimer increased their price objective on shares of UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. . SVB Leerink upped their price objective on shares of UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Barclays upped their target price on shares of UnitedHealth Group from $495.00 to $565.00 and gave the company an “overweight” rating in a research report on Wednesday, March 30th. Finally, Royal Bank of Canada set a $563.00 target price on shares of UnitedHealth Group and gave the company an “outperform” rating in a research note on Monday, April 18th. Three analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a “Moderate Buy” rating and an average target price of $578.95.

Internal Services

In other news, the Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, May 16. The stock sold at an average price of $493.25, for a total value of $1,233,125.00. After completing the sale, the director now owns 1,220,000 shares of the company’s stock, valued at $601,765,000. The transaction was disclosed in a document filed with the SEC, which is available now This hyperlink. In other news, the Director Frederick William McNabb III acquired 89 shares of the business’s stock in a transaction that occurred on Thursday, May 26. The stock was acquired at a price of $504.32 per share, with a value of $44,884.48. Following the completion of the transaction, the director now owns 11,259 shares of the company’s stock, valued at approximately $5,678,138.88. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed via this link. Also, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction dated Monday, May 16th. The stock was sold at a price of $493.25, for a total transaction of $1,233,125.00. Following the sale, the director now owns 1,220,000 shares of the company’s stock, valued at approximately $601,765,000. Disclosures for these products can be found Here. Over the last 90 days, insiders sold 17,649 shares of company stock valued at $9,071,142. 0.40% of the stock is owned by insiders.

Profile of UnitedHealth Group

(Get Votes)

UnitedHealth Group Incorporated operates as a diversified healthcare company in the United States. It operates in four divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare division offers consumer-focused and service-based health plans to national employers, state employers, mid-sized employers, small businesses, and individuals; Providing medical and health care services to people aged 50 and over who are meeting their needs for preventive and curative care, as well as services to deal with chronic diseases and other special problems for the elderly; Medicaid plans, children’s health insurance and health care programs; health and teeth; and medical and clinical services.

Featured Articles

Want to see what other hedge funds are doing at UNH? Go to HoldingsChannel.com for current 13F filings and insider trading for UnitedHealth Group Incorporated (NYSE: UNHGet Votes).



Receive UnitedHealth Group News & Reviews Daily – Enter your email address below to receive a concise daily summary of the latest news and expert opinions on UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter .